Inactive Instrument
Ocata Therapeutics Inc Stock
Stocks
US67457L1008
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
John Heffernan
PRN | Corporate Officer/Principal | - | 2015-02-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Toru Yoshimitsu
BRD | Director/Board Member | 63 | - |
Masaaki Hirano
BRD | Director/Board Member | 59 | - |
| Director/Board Member | 53 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.19% | -2.90% | +56.40% | +69.15% | 65.45B | ||
| -0.14% | -1.96% | +8.83% | +89.74% | 58.93B | ||
| +0.06% | +0.51% | +26.04% | +87.89% | 55.21B | ||
| -0.97% | -4.83% | +9.83% | +113.88% | 46.1B | ||
| -2.83% | -8.73% | +15.31% | +22.34% | 42.49B | ||
| +3.61% | +3.86% | +22.82% | +46.39% | 35.56B | ||
| -0.24% | -11.77% | +125.89% | +647.44% | 34.57B | ||
| +0.03% | -1.80% | +82.52% | +57.74% | 32.46B | ||
| +20.58% | +19.64% | -28.35% | +482.03% | 26.28B | ||
| Average | +2.25% | -3.08% | +35.48% | +179.62% | 44B | |
| Weighted average by Cap. | +1.27% | -2.90% | +34.88% | +149.70% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















